Using breakthrough, patented technology, the Dominion can provide 3D images at a rate of thirty frames per second and display them in less than one second - thereby meeting the definition of real-time dynamic imaging. The system combines the speed advantage of high-speed photo fluoroscopy with the benefits of 3D imaging and the precision of computed tomography (CT).
Burbank, CA (PRWEB) February 20, 2008
Imaging3™, Inc, (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, is proud to announce Frost & Sullivan has recognized Imaging3, Inc. with the 2008 North American Medical Imaging Product Innovation of the Year Award for the Dominion Vi Scanner™.
Quoting Nadim Daher, Frost & Sullivan Research Analyst, "The Dominion combines speed and accuracy to offer fluoroscopic imaging in 3D, that is, real-time 3D imaging. It is the only system capable of 3D imaging in real time, which makes it a valuable clinical tool in a wide array of applications. Its cost effectiveness and versatility make the Dominion an exceptional asset for today's healthcare enterprise."
"3D imaging has become a reality in the medical imaging world. Its clinical utility is further demonstrated every day in radiology, as well as in various specialties, where it provides physicians with a more intuitive depiction of anatomy and function, non-invasively. However, the techniques that today are described as four-dimensional (4D) imaging still require lengthy post-processing times, which limit their clinical utility and hamper their routine utilization."
"Using breakthrough, patented technology, the Dominion can provide 3D images at a rate of thirty frames per second and display them in less than one second - thereby meeting the definition of real-time dynamic imaging. The system combines the speed advantage of high-speed photo fluoroscopy with the benefits of 3D imaging and the precision of computed tomography (CT)."
"The Dominion can be utilized for both diagnostic and interventional procedures, in a variety of clinical areas including trauma, pain management, pediatrics, orthopedics, sports medicine, cardiovascular imaging, and neuro-vascular imaging. During interventional procedures in particular, its dynamic 3D imaging capabilities make the Dominion a useful image guidance tool to assist in placing catheters and medical devices and in performing a broad range of surgical interventions. Current devices used for image guidance - such as ultrasound - are limited to 2D imaging and/or offer poor image quality, which makes them less practical and less reliable."
"Therefore, the Dominion can further enable minimally invasive surgery by providing a more robust modality, with the end-result of improving surgical productivity as well as patient safety. Given its light-weight, small-footprint profile, the Dominion is a truly mobile imaging system that can go through any doorway and be moved around freely to where it is needed. This allows bringing the equipment to the patient at the point of care, thereby offering the flexibility and timesavings that are so critical in an acute care environment."
For more information about Frost & Sullivan's Best Practices Awards, go to http://www.awards.frost.com.
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at http://www.imaging3.com/
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.